Tremor
TrialsCompanies

Not investment advice.

Tremor shows what changed in public records. It never tells anyone to buy or sell. Many trial edits are harmless paperwork. Data from ClinicalTrials.gov, the SEC, and the Federal Register.

PrivacyTerms

CTMX

CytomX Therapeutics, Inc.

Tremor tracks 1 of its cancer trials.

Company-wide warning signs

These add points to every one of this company's trials.

None right now.

Trials

  • CTMXCytomX Therapeutics
    0Calm

    Study of Varsetatug Masetecan in Combination With Anti-Cancer Therapies in Colorectal Cancer

    Not started yetPhase 1/2368 patientsMain results: Feb 2029

Key executives leaving

From the last 12 months of the company's SEC reports.

None found.

Insider trades (last 6 months)

“Insiders” are executives, board members, and big shareholders. Many of their sales are pre-planned: scheduled months ahead under a legal plan (called 10b5-1), so they usually say little. Tremor only counts sales that weren't pre-planned.

1 sale (1 not pre-planned) · 0 purchases

  • Ogden ChristopherChief Financial Officer · Jun 15, 2026Sold 1,624 sharesabout $5 thousand · not pre-planned

Recent SEC filings

Public companies must report important news and their finances to the SEC, the US agency that oversees the stock market.

  • Shared quarterly resultsNews report (8-K)Nov 5, 2026
  • Quarterly reportQuarterly report (10-Q)Nov 5, 2026
  • Shared quarterly resultsNews report (8-K)Aug 6, 2026
  • Quarterly reportQuarterly report (10-Q)Aug 6, 2026
  • An executive or board member joined or leftNews report (8-K)Jul 27, 2026

Money left

Coming soon: how many months of cash the company has, from its quarterly reports.
An executive or board member joined or leftNews report (8-K)
Jun 22, 2026
  • Signed a major agreementNews report (8-K)Jun 3, 2026